(Q33709242)

28 July 2017

1 reference

title

Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy (English)

1 reference

28 July 2017

1 reference

Stoof JC

1

1 reference

28 July 2017

Winogrodzka A

2

1 reference

28 July 2017

van Muiswinkel FL

3

1 reference

28 July 2017

Wolters EC

4

1 reference

28 July 2017

Voorn P

5

1 reference

28 July 2017

Groenewegen HJ

6

1 reference

28 July 2017

Booij J

7

1 reference

28 July 2017

Drukarch B

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

European Journal of Pharmacology

28 July 2017

1 reference

28 July 2017

375

1 reference

28 July 2017

75-86

1 reference

28 July 2017

1-3

1 reference

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Antibodies to reduced glutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Biochemical effects of dithiolthiones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Dopaminergic mechanisms in hemiparkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Effect of D1 receptor stimulation in normal and MPTP monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Biochemical and toxicological properties of the oxidation products of catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Dopamine D1 receptor desensitization profile in MPTP-lesioned primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Anethole dithiolethione: biochemical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Glutathione peroxidase, glial cells and Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Primate models of movement disorders of basal ganglia origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

1,2-Dithiol-3-thione analogs: effects on NAD(P)H:quinone reductase and glutathione levels in murine hepatoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Biosynthesis, structure, and function of neuromelanin and its relation to Parkinson's disease: a critical update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The neostriatal mosaic: multiple levels of compartmental organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Parkinson's disease: prospects for improved drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Antisera to glutathione: characterization and immunocytochemical application to the rat cerebellum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Antioxidant response element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Understanding cell death in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Protective effects of anethole dithiolethione against oxidative stress-induced cytotoxicity in human Jurkat T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Glutathione peroxidase activity in Parkinson's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Identification of dithiolethiones with better chemopreventive properties than oltipraz

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Overview of enzymes of drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Clinical and [18F] dopa PET findings in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The Creation of the Anglican Diocese of Liverpool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethiones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

NADPH cytochrome P-450 reductase in rat, mouse and human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Human class Mu glutathione transferases, in particular isoenzyme M2-2, catalyze detoxication of the dopamine metabolite aminochrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Distribution of DT diaphorase in the rat brain: biochemical and immunohistochemical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Histochemical evaluation of glutathione in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The oxidative metabolism of catecholamines in the brain: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Seizure promotion by D1 agonists does not correlate with other dopaminergic properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

New insights into dopamine receptors in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-ioduced parkinsonism in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Nonsteroidal anti-inflammatory drugs enhance glutathione S-transferase theta levels in rat colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Dopamine D1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Detoxication enzymes and chemoprevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

Presence of glutathione immunoreactivity in cultured neurones and astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Antioxidant-inducible genes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900260-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00260-5

1 reference

28 July 2017

1 reference